These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15384209)

  • 1. Preoperative chemoradiotherapy shows promise in gastric cancer.
    Lindsey H
    Lancet Oncol; 2004 Sep; 5(9):519. PubMed ID: 15384209
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative radiochemotherapy in gastric cancer: another ongoing shift from adjuvant to neoadjuvant?
    Allal AS
    J Clin Oncol; 2005 Jun; 23(16):3870; author reply 3870-1. PubMed ID: 15923598
    [No Abstract]   [Full Text] [Related]  

  • 3. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005.
    Van Cutsem E; Dicato M; Arber N; Benson A; Cunningham D; Diaz-Rubio E; Glimelius B; Goldberg R; Haller D; Haustermans K; Koo-Kang Y; Labianca R; Lang I; Minsky B; Nordlinger B; Roth A; Rougier P; Schmoll HJ; Sobrero A; Tabernero J; Szawlowski A; van de Velde C
    Ann Oncol; 2006 Jun; 17 Suppl 6():vi13-8. PubMed ID: 16809641
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysis.
    Kumagai K; Rouvelas I; Tsai JA; Mariosa D; Lind PA; Lindblad M; Ye W; Lundell L; Schuhmacher C; Mauer M; Burmeister BH; Thomas JM; Stahl M; Nilsson M
    Eur J Surg Oncol; 2015 Mar; 41(3):282-94. PubMed ID: 25491892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy.
    Valenti V; Hernandez-Lizoaín JL; Beorlegui MC; Diaz-Gozalez JA; Regueira FM; Rodriguez JJ; Viudez A; Sola I; Cienfuegos JA
    J Surg Oncol; 2011 Aug; 104(2):124-9. PubMed ID: 21509785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
    Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
    Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Management of Locally Advanced Junction Esophagogastric Adenocarcinoma.
    Birla R; Hoara P; Caragui A; Cristian M; Constantinoiu S
    Chirurgia (Bucur); 2018; 113(1):38-45. PubMed ID: 29509530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemoradiotherapy in non-cardia gastric cancer patients--does it improve survival?
    Saedi HS; Mansour-Ghanaei F; Joukar F; Shafaghi A; Shahidsales S; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2014; 15(20):8667-71. PubMed ID: 25374187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophagogastric junction and gastric adenocarcinoma: neoadjuvant and adjuvant therapy, and future directions.
    Sandler S
    Oncology (Williston Park); 2014 Jun; 28(6):505-12. PubMed ID: 25134325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches.
    Davidson M; Chau I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):327-338. PubMed ID: 29431018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.
    Ajani JA; Mansfield PF; Crane CH; Wu TT; Lunagomez S; Lynch PM; Janjan N; Feig B; Faust J; Yao JC; Nivers R; Morris J; Pisters PW
    J Clin Oncol; 2005 Feb; 23(6):1237-44. PubMed ID: 15718321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives in adjuvant therapy of gastric cancer.
    De Vita F; Vecchione L; Galizia G; Di Martino N; Fabozzi T; Catalano G; Ciardiello F; Orditura M
    Oncology; 2009; 77 Suppl 1():38-42. PubMed ID: 20130430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
    Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
    Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of preoperative chemoradiotherapy for resectable gastric cancer.
    Lowy AM; Feig BW; Janjan N; Rich TA; Pisters PW; Ajani JA; Mansfield PF
    Ann Surg Oncol; 2001 Jul; 8(6):519-24. PubMed ID: 11456051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
    Slagter AE; Jansen EPM; van Laarhoven HWM; van Sandick JW; van Grieken NCT; Sikorska K; Cats A; Muller-Timmermans P; Hulshof MCCM; Boot H; Los M; Beerepoot LV; Peters FPJ; Hospers GAP; van Etten B; Hartgrink HH; van Berge Henegouwen MI; Nieuwenhuijzen GAP; van Hillegersberg R; van der Peet DL; Grabsch HI; Verheij M
    BMC Cancer; 2018 Sep; 18(1):877. PubMed ID: 30200910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG.
    Leong T; Smithers BM; Haustermans K; Michael M; Gebski V; Miller D; Zalcberg J; Boussioutas A; Findlay M; O'Connell RL; Verghis J; Willis D; Kron T; Crain M; Murray WK; Lordick F; Swallow C; Darling G; Simes J; Wong R
    Ann Surg Oncol; 2017 Aug; 24(8):2252-2258. PubMed ID: 28337660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined-modality therapy for gastric cancer.
    Yao JC; Mansfield PF; Pisters PW; Feig BW; Janjan NA; Crane C; Ajani JA
    Semin Surg Oncol; 2003; 21(4):223-7. PubMed ID: 14648779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens?
    Ajani JA; Correa AM; Swisher SG; Wu TT
    J Clin Oncol; 2007 Sep; 25(27):4315-6. PubMed ID: 17878485
    [No Abstract]   [Full Text] [Related]  

  • 19. Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered?
    Lane WO; Nussbaum DP; Sun Z; Blazer DG
    J Surg Oncol; 2018 Jun; 117(8):1708-1715. PubMed ID: 29799615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
    Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
    J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.